Effects of Walking and Home-Based Pulmonary Rehabilitation on Anxiety and Sleep Quality
NCT ID: NCT06862713
Last Updated: 2025-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2024-04-01
2025-04-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to evaluate the effects of an 8-week home-based PR program on cardiopulmonary parameters, respiratory function, anxiety levels, and sleep quality in COPD patients.
As a randomized controlled trial, COPD patients will be divided into experimental and control groups. Pre- and post-tests will include the 6-minute walking test (6 MWT), dyspnea score, oxygen saturation, respiratory function tests (FEV1, FVC, FEV1/FVC, FEF 25-75), anxiety (STAI-I and STAI-II), and sleep quality (PSQI). Post-tests will be collected after the eight-week intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Home-Based Monitoring, Exercise Training
NCT06128902
Investigation of Walking Training With Different Slope Types in COPD Patients
NCT06283004
Changes in Dyspnea, Activity and Sleep in COPD by Video-Based Breathing Exercises
NCT06477367
Effect of Home Based Pulmonary Rehabilitation on Exacerbation and Hospital Admission in Severe COPD
NCT05738720
Home-based Pulmonary Rehabilitation for COPD Patients
NCT04820257
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although there are various treatment options that can reduce COPD symptoms (smoking cessation, pharmacological treatment, vaccines, etc.), there is no treatment yet that can return lung functions to their pre-disease normal state. Therefore, pulmonary rehabilitation is an important scientifically based, safe, and effective non-pharmacological treatment option recommended in guidelines for COPD patients to maintain the patient's quality of life. The most important component of pulmonary rehabilitation in COPD is exercise training. Pulmonary rehabilitation has been shown to increase exercise tolerance in patients with COPD, reduce re-admissions to hospital, and improve health status. Home-based pulmonary rehabilitation stands out as an alternative model that can overcome these barriers and increase access and participation. Initial studies suggest that home-based PR is safe and may improve clinical outcomes. The effectiveness of pulmonary rehabilitation in COPD patients is directly related to the patient's compliance with the program.
Difficulties experienced due to COPD also negatively affect the psychosocial status of patients. Shortness of breath can trigger anxiety and panic attacks in COPD patients. Anxiety and depression can worsen the health status of COPD patients and cause increased morbidity. In a study was determined that exercise improves anxiety and depression symptoms in COPD patients and increases the quality of life of patients. In addition, patients often complain of chronic insomnia; nearly 50% of patients report difficulty falling asleep, staying asleep, or experiencing unrefreshing sleep. The fact that there is no study in our country on non-pharmacological methods (pulmonary rehabilitation and exercise) to improve both anxiety and sleep quality in COPD patients and that an individual-focused pulmonary rehabilitation training program has been designed reveals the importance of this study and its contribution to the literature. This study evaluates the effects of walking and home-based pulmonary rehabilitation programs on anxiety and sleep quality in COPD patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
pulmonary rehabilitation exercise + standard protocol
pulmonary rehabilitation exercise
pulmonary rehabilitation exercise + standard protocol
Control group
standard protocol
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulmonary rehabilitation exercise
pulmonary rehabilitation exercise + standard protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to speak and understand Turkish
* Baseline saturation \> 85%
* Confirmed stage II or stage III COPD diagnosis according to GOLD guidelines
* No infection or COPD exacerbation in the last 3 months
* Not participating in a pulmonary rehabilitation program in the last 3 months
* Able to walk without assistance and lift weights up to 2 kg
* No history of serious and/or unstable heart disease, neuromuscular disease, orthopedic disease, or mental illness that may affect daily physical activities
* Agree to participate in the study and give written informed consent
* No communication problems
Exclusion Criteria
* Patients receiving continuous oxygen therapy
* Patients with a history of pulmonary hypertension, malignancy, pulmonary thromboembolism, obstructive sleep apnea, unstable angina, or myocardial infarction
* Patients with a heart rate above 120/min
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bilecik Seyh Edebali Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SABAHAT COŞKUN, Doç.Dr.
Role: STUDY_DIRECTOR
Bilecik Şeyh Edebali Üniversity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gulhane Education and Research Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Xu J, He S, Han Y, Pan J, Cao L. Effects of modified pulmonary rehabilitation on patients with moderate to severe chronic obstructive pulmonary disease: A randomized controlled trail. Int J Nurs Sci. 2017 Jun 27;4(3):219-224. doi: 10.1016/j.ijnss.2017.06.011. eCollection 2017 Jul 10.
Zhang Y, Li G, Liu C, Guan J, Zhang Y, Shi Z. Comparing the efficacy of different types of exercise for the treatment and prevention of depression in youths: a systematic review and network meta-analysis. Front Psychiatry. 2023 Jun 2;14:1199510. doi: 10.3389/fpsyt.2023.1199510. eCollection 2023.
Yang PY, Ho KH, Chen HC, Chien MY. Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review. J Physiother. 2012;58(3):157-63. doi: 10.1016/S1836-9553(12)70106-6.
Soler X, Diaz-Piedra C, Ries AL. Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD. 2013 Apr;10(2):156-63. doi: 10.3109/15412555.2012.729622. Epub 2013 Mar 20.
Li M, An X, Wang Q, Ma J, Wang Y, Ma J. Effect of Hope Theory combined with active cycle of breathing techniques on pulmonary rehabilitation among COPD patients: A quasi-experiment study. Appl Nurs Res. 2024 Oct;79:151842. doi: 10.1016/j.apnr.2024.151842. Epub 2024 Aug 26.
Li J, Lu Y, Li N, Li P, Su J, Wang Z, Wang T, Yang Z, Yang Y, Chen H, Xiao L, Duan H, Wu W, Liu X. Muscle metabolomics analysis reveals potential biomarkers of exercise-dependent improvement of the diaphragm function in chronic obstructive pulmonary disease. Int J Mol Med. 2020 Jun;45(6):1644-1660. doi: 10.3892/ijmm.2020.4537. Epub 2020 Mar 12.
Cox NS, Pepin V, Burge AT, Hill CJ, Lee AL, Bondarenko J, Moore R, Nicolson C, Lahham A, Parwanta Z, McDonald CF, Holland AE. Pulmonary Rehabilitation does not Improve Objective Measures of Sleep Quality in People with Chronic Obstructive Pulmonary Disease. COPD. 2019 Feb;16(1):25-29. doi: 10.1080/15412555.2019.1567701. Epub 2019 Mar 19.
Higginson R, Parry A. Managing chronic obstructive pulmonary disease in the community setting. Br J Community Nurs. 2018 Jan 2;23(1):6-12. doi: 10.12968/bjcn.2018.23.1.6.
Bains D, Chahal A, Shaphe MA, Kashoo FZ, Ali T, Alghadir AH, Khan M. Effects of Muscle Energy Technique and Joint Manipulation on Pulmonary Functions, Mobility, Disease Exacerbations, and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients: A Quasiexperimental Study. Biomed Res Int. 2022 Jul 30;2022:5528724. doi: 10.1155/2022/5528724. eCollection 2022.
Alnawwar MA, Alraddadi MI, Algethmi RA, Salem GA, Salem MA, Alharbi AA. The Effect of Physical Activity on Sleep Quality and Sleep Disorder: A Systematic Review. Cureus. 2023 Aug 16;15(8):e43595. doi: 10.7759/cureus.43595. eCollection 2023 Aug.
Aiello M, Frizzelli A, Pisi R, Accogli R, Marchese A, Carlacci F, Bondarenko O, Tzani P, Chetta A. Effects of Daily Physical Activity on Exercise Capacity in Chronic Obstructive Pulmonary Disease. Medicina (Kaunas). 2024 Jun 21;60(7):1026. doi: 10.3390/medicina60071026.
Adeloye D, Agarwal D, Barnes PJ, Bonay M, van Boven JF, Bryant J, Caramori G, Dockrell D, D'Urzo A, Ekstrom M, Erhabor G, Esteban C, Greene CM, Hurst J, Juvekar S, Khoo EM, Ko FW, Lipworth B, Lopez-Campos JL, Maddocks M, Mannino DM, Martinez FJ, Martinez-Garcia MA, McNamara RJ, Miravitlles M, Pinnock H, Pooler A, Quint JK, Schwarz P, Slavich GM, Song P, Tai A, Watz H, Wedzicha JA, Williams MC, Campbell H, Sheikh A, Rudan I. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade. J Glob Health. 2021 Oct 9;11:15003. doi: 10.7189/jogh.11.15003. eCollection 2021.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bilecik12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.